{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:46:57Z","timestamp":1787849217912,"version":"build-2784847793"},"reference-count":86,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.beha.2005.01.024","type":"journal-article","created":{"date-parts":[[2005,7,17]],"date-time":"2005-07-17T12:33:11Z","timestamp":1121603591000},"page":"673-688","source":"Crossref","is-referenced-by-count":124,"title":["Neurological aspects of multiple myeloma and related disorders"],"prefix":"10.1016","volume":"18","author":[{"given":"Angela","family":"Dispenzieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2005.01.024_bib1","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/jama.1953.02940260008003","article-title":"Neurosurgical treatment of compression of the spinal cord caused by myeloma","volume":"153","author":"Svein","year":"1953","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.beha.2005.01.024_bib2","first-page":"429","article-title":"Multiple myeloma in Iowa","volume":"64","author":"Callis","year":"1974","journal-title":"J Iowa Med Soc"},{"issue":"11","key":"10.1016\/j.beha.2005.01.024_bib3","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/0277-5379(91)90020-E","article-title":"Changing clinical presentation of multiple myeloma","volume":"27","author":"Riccardi","year":"1991","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.beha.2005.01.024_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00005792-198007000-00005","article-title":"Plasma cell neoplasia with peripheral polyneuropathy. A study of five cases and a review of the literature","volume":"59","author":"Driedger","year":"1980","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.beha.2005.01.024_bib5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3171\/jns.1980.53.6.0741","article-title":"Treatment of spinal epidural metastases. Randomized prospective comparison of laminectomy and radiotherapy","volume":"53","author":"Young","year":"1980","journal-title":"J Neurosurg"},{"key":"10.1016\/j.beha.2005.01.024_bib6","series-title":"Neurological Therapeutics","article-title":"Neuropathy Associated with the Monoclonal Gammopathies","author":"Kyle","year":"2003"},{"issue":"1","key":"10.1016\/j.beha.2005.01.024_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2141.2002.03401.x","article-title":"Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations","volume":"117","author":"Fassas","year":"2002","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.beha.2005.01.024_bib8","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/1097-0142(19921001)70:7<1899::AID-CNCR2820700716>3.0.CO;2-3","article-title":"Leptomeningeal myelomatosis presenting with mental status changes and other neurologic findings","volume":"70","author":"Leifer","year":"1992","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.beha.2005.01.024_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0022-510X(93)90297-C","article-title":"Clinical, neurophysiological and immunological evidence of polyneuropathy in patients with monoclonal gammopathies","volume":"114","author":"Vrethem","year":"1993","journal-title":"J Neurologic Sci"},{"issue":"5","key":"10.1016\/j.beha.2005.01.024_bib10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/archneur.1971.00490050038003","article-title":"The neuropathy of multiple myeloma. An electrophysiological and histological study","volume":"25","author":"Walsh","year":"1971","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.beha.2005.01.024_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1212\/WNL.31.1.24","article-title":"The spectrum of peripheral neuropathy in myeloma","volume":"31","author":"Kelly","year":"1981","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.beha.2005.01.024_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00005792-198007000-00006","article-title":"Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature","volume":"59","author":"Bardwick","year":"1980","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.beha.2005.01.024_bib13","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long-term outcome","volume":"101","author":"Dispenzieri","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2005.01.024_bib14","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.34.6.712","article-title":"The Crow-Fukase syndrome: a study of 102 cases in Japan","volume":"34","author":"Nakanishi","year":"1984","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.beha.2005.01.024_bib15","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/(SICI)1097-4598(199811)21:11<1390::AID-MUS5>3.0.CO;2-4","article-title":"Overproduction of vascular endothelial growth factor\/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome","volume":"21","author":"Watanabe","year":"1998","journal-title":"Muscle and Nerve"},{"issue":"4","key":"10.1016\/j.beha.2005.01.024_bib16","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/art.1780400430","article-title":"Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor","volume":"40","author":"Soubrier","year":"1997","journal-title":"Arthritis Rheumatism"},{"issue":"3 Pt 1","key":"10.1016\/j.beha.2005.01.024_bib17","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1164\/ajrccm.157.3.9707095","article-title":"Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines","volume":"157","author":"Lesprit","year":"1998","journal-title":"Am J Respir Critical Care Med"},{"key":"10.1016\/j.beha.2005.01.024_bib18","first-page":"2005","article-title":"Peripheral blood stem cell transplant (PBSCT) in sixteen patients with POEMS syndrome. And a review of the literature","author":"Dispenzieri","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2005.01.024_bib19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1212\/WNL.33.2.202","article-title":"Osteosclerotic myeloma and peripheral neuropathy","volume":"33","author":"Kelly","year":"1983","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.beha.2005.01.024_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/mus.10182","article-title":"Patterns of nerve conduction abnormalities in POEMS syndrome","volume":"26","author":"Sung","year":"2002","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.beha.2005.01.024_bib21","first-page":"1474","article-title":"An autopsied case of Crow-Fukase syndrome. A neuropathological study with emphasis on spinal roots","volume":"27","author":"Umehara","year":"1987","journal-title":"Rinsho Shinkeigaku Clinical Neurology"},{"issue":"3","key":"10.1016\/j.beha.2005.01.024_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ana.410170306","article-title":"Axonal attenuation and secondary segmental demyelination in myeloma neuropathies","volume":"17","author":"Ohi","year":"1985","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.beha.2005.01.024_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01913120309941","article-title":"Uncompacted myelin lamellae in peripheral nerve biopsy","volume":"27","author":"Vital","year":"2003","journal-title":"Ultrastructural Pathology"},{"issue":"6","key":"10.1016\/j.beha.2005.01.024_bib24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0002-9343(94)90350-6","article-title":"POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome. [Review] [110 refs]","volume":"97","author":"Soubrier","year":"1994","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.beha.2005.01.024_bib25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.beha.2005.01.024_bib26","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/jcp.33.7.617","article-title":"Paraproteinaemia in neurological disease: incidence, associations, and classification of monoclonal immunoglobulins","volume":"33","author":"Kahn","year":"1980","journal-title":"J Clin Pathol"},{"issue":"11","key":"10.1016\/j.beha.2005.01.024_bib27","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.31.11.1480","article-title":"Prevalence of monoclonal protein in peripheral neuropathy","volume":"31","author":"Kelly","year":"1981","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.beha.2005.01.024_bib28","first-page":"99","article-title":"Peripheral neuropathy and paraproteinemia: an immunohistochemical and serologic study","volume":"4","author":"Johansen","year":"1985","journal-title":"Clin Neuropathol"},{"key":"10.1016\/j.beha.2005.01.024_bib29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1749-6632.1971.tb13560.x","article-title":"Pathologic conditions associated with plasma cell dyscrasias: a study of 806 cases","volume":"190","author":"Isobe","year":"1971","journal-title":"Ann NY Acad Sci"},{"issue":"6","key":"10.1016\/j.beha.2005.01.024_bib30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1600-0404.1992.tb06033.x","article-title":"Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies","volume":"85","author":"Nobile-Orazio","year":"1992","journal-title":"Acta Neurologica Scandinavica"},{"issue":"1","key":"10.1016\/j.beha.2005.01.024_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ajh.2830450105","article-title":"Peripheral neuropathy in IgM monoclonal gammopathy and Waldenstrom's macroglobulinemia: a frequent complication in elderly males with low MAG-reactive serum monoclonal component","volume":"45","author":"Baldini","year":"1994","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.beha.2005.01.024_bib32","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1212\/WNL.43.7.1304","article-title":"Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS","volume":"43","author":"Suarez","year":"1993","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.beha.2005.01.024_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.410300111","article-title":"Neuropathy associated with monoclonal gammopathies of undetermined significance","volume":"30","author":"Gosselin","year":"1991","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.beha.2005.01.024_bib34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF00319857","article-title":"The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings","volume":"238","author":"Yeung","year":"1991","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.beha.2005.01.024_bib35","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/(SICI)1097-4598(199907)22:7<800::AID-MUS2>3.0.CO;2-F","article-title":"Autoantibodies associated with peripheral neuropathy","volume":"22","author":"Quarles","year":"1999","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.beha.2005.01.024_bib36","first-page":"301","article-title":"Peripheral neuropathy and anti-MAG antibodies","volume":"3","author":"Latov","year":"1988","journal-title":"Crit Rev Neurobiol"},{"issue":"2","key":"10.1016\/j.beha.2005.01.024_bib37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood.V62.2.280.280","article-title":"Waldenstrom's macroglobulinemia and peripheral neuropathy: a clinical and immunologic study of 25 patients","volume":"62","author":"Dellagi","year":"1983","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2005.01.024_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/(SICI)1097-4598(199801)21:1<55::AID-MUS8>3.0.CO;2-F","article-title":"Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M protein antibody activity and clinical\/electrophysiological features in 40 cases","volume":"21","author":"Chassande","year":"1998","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.beha.2005.01.024_bib39","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/WNL.33.11.1397","article-title":"Peripheral neuropathy with IgM kappa monoclonal immunoglobulin directed against myelin-associated glycoprotein","volume":"33","author":"Melmed","year":"1983","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.beha.2005.01.024_bib40","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/archneur.1988.00520360073015","article-title":"Polyneuropathies associated with IgM monoclonal gammopathies","volume":"45","author":"Kelly","year":"1988","journal-title":"Arch Neurol"},{"issue":"12","key":"10.1016\/j.beha.2005.01.024_bib41","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/mus.880131205","article-title":"The electrodiagnostic findings in polyneuropathies associated with IgM monoclonal gammopathies","volume":"13","author":"Kelly","year":"1990","journal-title":"Muscle Nerve"},{"issue":"Pt 2","key":"10.1016\/j.beha.2005.01.024_bib42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/brain\/118.2.359","article-title":"Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy","volume":"118","author":"Simmons","year":"1995","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.beha.2005.01.024_bib43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1097-4598(200001)23:1<73::AID-MUS9>3.0.CO;2-5","article-title":"Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammopathy","volume":"23","author":"Notermans","year":"2000","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.beha.2005.01.024_bib44","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.48.2.321","article-title":"Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy","volume":"48","author":"Gorson","year":"1997","journal-title":"Neurology"},{"issue":"Pt 4","key":"10.1016\/j.beha.2005.01.024_bib45","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/brain\/123.4.710","article-title":"Long-term prognosis of neuropathy associated with anti-MAG IgM M- proteins and its relationship to immune therapies","volume":"123","author":"Nobile-Orazio","year":"2000","journal-title":"Brain"},{"issue":"21","key":"10.1016\/j.beha.2005.01.024_bib46","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJM199111213252105","article-title":"Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance","volume":"325","author":"Dyck","year":"1991","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.beha.2005.01.024_bib47","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ana.410400516","article-title":"A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy","volume":"40","author":"Dalakas","year":"1996","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.beha.2005.01.024_bib48","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/jnnp.69.2.279","article-title":"A randomised double blind trial versus placebo does not confirm the benefit of alpha-interferon in polyneuropathy associated with monoclonal IgM","volume":"69","author":"Mariette","year":"2000","journal-title":"J Neurol, Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.beha.2005.01.024_bib49","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/jnnp.59.3.243","article-title":"Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. IgM-associated Polyneuropathy Study Group","volume":"59","author":"Oksenhendler","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.beha.2005.01.024_bib50","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s00415-002-0808-z","article-title":"A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy","volume":"249","author":"Comi","year":"2002","journal-title":"J Neurol"},{"issue":"11","key":"10.1016\/j.beha.2005.01.024_bib51","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJM198009113031105","article-title":"Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin","volume":"303","author":"Latov","year":"1980","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.beha.2005.01.024_bib52","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jnnp.66.5.575","article-title":"Successful treatment of IgM paraproteinaemic neuropathy with fludarabine","volume":"66","author":"Wilson","year":"1999","journal-title":"J Neurol, Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.beha.2005.01.024_bib53","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1212\/WNL.52.8.1701","article-title":"IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab","volume":"52","author":"Levine","year":"1999","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.beha.2005.01.024_bib54","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/mus.10359","article-title":"Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies","volume":"27","author":"Renaud","year":"2003","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.beha.2005.01.024_bib55","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/jnnp.74.4.485","article-title":"Treatment of IgM antibody associated polyneuropathies using rituximab","volume":"74","author":"Pestronk","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.beha.2005.01.024_bib56","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1212\/WNL.40.4.595","article-title":"Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes","volume":"40","author":"Younger","year":"1990","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.beha.2005.01.024_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ana.410060102","article-title":"The natural history of peripheral neuropathy in primary systemic amyloidosis","volume":"6","author":"Kelly","year":"1979","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.beha.2005.01.024_bib58","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0002-9343(98)00037-0","article-title":"Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy","volume":"104","author":"Rajkumar","year":"1998","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.beha.2005.01.024_bib59","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/mus.880060706","article-title":"The electrodiagnostic findings in peripheral neuropathy associated with monoclonal gammopathy","volume":"6","author":"Kelly","year":"1983","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.beha.2005.01.024_bib60","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5858\/2000-124-0114-PNAISN","article-title":"Peripheral nerve amyloidosis in sural nerve biopsies: a clinicopathologic analysis of 13 cases","volume":"124","author":"Rajani","year":"2000","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"10.1016\/j.beha.2005.01.024_bib61","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood.V91.10.3662","article-title":"Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients","volume":"91","author":"Comenzo","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.024_bib62","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archneur.1960.00450050084010","article-title":"Neurologic aspects of Waldenstrom's macroglobulinemia; report of a case","volume":"3","author":"Logothetis","year":"1960","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.beha.2005.01.024_bib63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00314040","article-title":"Reactivity of sera and isolated monoclonal IgM from patients with Waldenstrom's macroglobulinaemia with peripheral nerve myelin","volume":"232","author":"Harbs","year":"1985","journal-title":"J Neurol"},{"issue":"9","key":"10.1016\/j.beha.2005.01.024_bib64","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/WNL.37.9.1506","article-title":"Peripheral neuropathy in macroglobulinemia: incidence and antigen-specificity of M proteins","volume":"37","author":"Nobile-Orazio","year":"1987","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.beha.2005.01.024_bib65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1212\/WNL.33.1.19","article-title":"Demyelinating neuropathy and monoclonal IgM antibody to myelin-associated glycoprotein","volume":"33","author":"Steck","year":"1983","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.beha.2005.01.024_bib66","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1212\/WNL.51.4.1210","article-title":"Nervous system dysfunction in Waldenstrom's macroglobulinemia: response to treatment","volume":"51","author":"Rudnicki","year":"1998","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.beha.2005.01.024_bib67","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9343(66)90200-2","article-title":"Cryoglobulinemia\u2014a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity","volume":"40","author":"Meltzer","year":"1966","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2005.01.024_bib68","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biological and clinical significance of cryoglobulins. A report of 86 cases","volume":"57","author":"Brouet","year":"1974","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.beha.2005.01.024_bib69","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/infdis\/162.2.569","article-title":"Hepatitis C virus in patients with cryoglobulinemia type II","volume":"162","author":"Pascual","year":"1990","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.beha.2005.01.024_bib70","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0002-9343(80)90390-3","article-title":"Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients","volume":"69","author":"Gorevic","year":"1980","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.beha.2005.01.024_bib71","first-page":"115","article-title":"Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias","volume":"88","author":"Monti","year":"1995","journal-title":"Qjm"},{"issue":"6","key":"10.1016\/j.beha.2005.01.024_bib72","first-page":"889","article-title":"Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations","volume":"19","author":"Ferri","year":"1992","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.beha.2005.01.024_bib73","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1212\/WNL.32.7.725","article-title":"The pathogenesis of cryoglobulinemic neuropathy","volume":"32","author":"Chad","year":"1982","journal-title":"Neurology"},{"issue":"Pt 3","key":"10.1016\/j.beha.2005.01.024_bib74","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/brain\/111.3.541","article-title":"Cryoglobulinaemic neuropathy. A clinical, morphological and immunocytochemical study of 8 cases","volume":"111","author":"Nemni","year":"1988","journal-title":"Brain"},{"issue":"3 Pt 1","key":"10.1016\/j.beha.2005.01.024_bib75","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/WNL.45.3.407","article-title":"Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy. Treatment with interferon alfa: case report and literature review","volume":"45","author":"Khella","year":"1995","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.beha.2005.01.024_bib76","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archneur.1988.00520350048015","article-title":"Peripheral neuropathy in essential mixed cryoglobulinemia","volume":"45","author":"Garcia-Bragado","year":"1988","journal-title":"Archives of Neurology"},{"issue":"10","key":"10.1016\/j.beha.2005.01.024_bib77","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood.V84.10.3336.3336","article-title":"Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study","volume":"84","author":"Dammacco","year":"1994","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2005.01.024_bib78","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0272-6386(95)90095-0","article-title":"Cryoglobulinemic glomerulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus [61 refs]","volume":"25","author":"Amico","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.beha.2005.01.024_bib79","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1136\/gut.34.2_Suppl.S144","article-title":"Interferon alfa-2b in mixed cryoglobulinaemia: a controlled crossover trial","volume":"34","author":"Ferri","year":"1993","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.beha.2005.01.024_bib80","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199403173301104","article-title":"Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus","volume":"330","author":"Misiani","year":"1994","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.beha.2005.01.024_bib81","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1046\/j.1365-2036.1999.00581.x","article-title":"Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia","volume":"13","author":"Calleja","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.beha.2005.01.024_bib82","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","article-title":"Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20","volume":"101","author":"Sansonno","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2005.01.024_bib83","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2005.01.024_bib84","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000183849","article-title":"Treatment of the renal involvement in mixed cryoglobulinemia with prolonged plasma exchange","volume":"43","author":"Ferri","year":"1986","journal-title":"Nephron"},{"issue":"6","key":"10.1016\/j.beha.2005.01.024_bib85","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0889-8588(05)70129-5","article-title":"Cryoglobulinemia","volume":"13","author":"Dispenzieri","year":"1999","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.beha.2005.01.024_bib86","first-page":"47","article-title":"Prolonged plasma exchange in the treatment of renal involvement in essential mixed cryoglobulinemia","volume":"1","author":"Bombardieri","year":"1983","journal-title":"Int J Artificial Organs"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692605000253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692605000253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T17:43:52Z","timestamp":1626198232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692605000253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S1521692605000253"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2005.01.024","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}